O T C
Dyadic International (NASDAQ: DYAI): A Unique Approach to World Vaccination (DYAI, AZN, MRNA, NVAX, PFE, JNJ, BNTX)

The vaccine story is set to take yet another twist and turn in the months ahead as the Biden administration faces the literally world-shaping task of playing a material leadership role in helping to vaccinate the entire world against Covid-19. This comes after better-than-expected results in the pathway to bringing something rapidly closing in on

ALKM – Alkame Confirms First PPE Shipment In Fulfillment Of $1 Million Sales Contract

  Las Vegas, Nevada, June 8, 2021 – McapMediaWire  – Alkame Holdings, Inc. (OTC Pink: ALKM), today confirmed the first shipment of Personal Protection Equipment (PPE) in fulfillment of a $1 million sales contract with Aladyn Protection Systems, LLC. Alkame and Aladyn entered into the agreement last month and have now finalized logistics details to

heliosDX and RushNet Inc. Sign Binding Letter of Intent to Acquire Laboratory and Target Additional Laboratory Acquisitions

  Alpharetta, GA, June 7, 2021 – RushNet, Inc (OTC PINK: RSHN) (“RushNet”) with merger/acquisition target heliosDX, is pleased to announce a Binding Letter of Intent by heliosdDX to acquire a privately held laboratory with $10,000,000 annual revenues processing more than 5,000 tests monthly with a capacity of 12,000 monthly UDS tests. The acquisition further

The Vaccine Investment Hypothesis, and What’s Next (AZN, JNJ, DYAI, BNTX)

The party is apparently “On” as far as the developed world’s sense of “reopening” is concerned. But the global truth is far removed from this celebration, as less than 20% of the world’s population have had access to a vaccine. The major vaccine producers struggle with the unit economics and production dynamics to solve this

Leading Vaccine Stocks Under the Microscope (PFE, NVAX, DYAI, MRNA)

The process of lining up the next wave of vaccines – Vax 2.0 – is likely already underway behind closed doors at major science institutes, throughout top research think-tanks, and at the home bases of the major vaccine-oriented pharma players. Vax 2.0 is no longer a theory. It’s already in the works. The Covid-19 variants

Could Dyadic International (DYAI) be a Dark Horse Vaccine MVP

Dyadic International Inc (NASDAQ: DYAI) continues to take strong steps as a dark horse candidate to reshape the global vaccine landscape. The company posted results and an in-depth update late last week, and it’s worth taking a closer look. For a little background, DYAI has a new approach that could become a better way to

Alkame Holdings Announces Aladyn Now Ready For First PPE Shipment Of $1 Million Sales Contract

  Las Vegas, Nevada – May 18, 2021 – McapMediaWire –  Alkame Holdings, Inc. (OTC Pink: ALKM), today announced Aladyn Protection Systems, LLC is initiating the first shipment of Personal Protection Equipment (PPE) form Alkame in conjunction with a recently announce $1 million sales contract. Aladyn is a global wholesale distributor of PPE supplies specializing

DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity

Dyadic International Inc (NASDAQ: DYAI) is in an interesting position, being one of the very few names in the anti-Covid space that offer a new path that isn’t simply a reproduction or tie-in to the big pharma game right now. DYAI has a new approach that isn’t new-age quote-unquote “science”, but a powerful new potential

Enerkon Solar International Inc. (ENKS) Announces its first Contingent Order for the SARS2 COVID19 15 second “Insta Test”

  New York, New York, May 11, 2021 – OTC PR WIRE – Enerkon Solar International Inc. (OTC Pink: ENKS) announces today its first Contingent Order for the SARS2 COVID19 15 second “Insta Test” as produced by Graphene Leaders Canada with Co sales via KrowdX and Coviklear Holdings (an ENKS wholly owned division). Mr. Benjamin

New Approaches to Covid-19 Treatment Enter the Picture

The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (NYSE: PFE), BioNTech SE – ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA), AstraZeneca plc (NASDAQ: AZN), Novavax Inc (NASDAQ: NVAX), Halberd Corp (OTC US: HALB), and Johnson & Johnson (NYSE: JNJ). The pandemic is under control. Or is it? In

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019